BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10487618)

  • 1. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Sugiyama T; Nishida T; Kumagai S; Nishio S; Fujiyoshi K; Okura N; Yakushiji M; Hiura M; Umesaki N
    Br J Cancer; 1999 Sep; 81(1):95-8. PubMed ID: 10487618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer].
    Nishio S; Kumagai S; Hirai N; Tomioka Y; Oota S; Fujiyoshi K; Hasuo Y; Sugiyama T; Nishida T; Kamura T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):429-35. PubMed ID: 10740637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
    Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified shortened administration schedule for neoadjuvant chemotherapy with irinotecan and cisplatin in locally advanced cervical cancer.
    Ren Y; Li Y; Liu J
    Int J Gynecol Cancer; 2011 May; 21(4):685-9. PubMed ID: 21543932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
    Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
    Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A modified administrated schedule for combination therapy with irinotecan and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical cancer--a report of 2 cases as a pilot study].
    Kumagai S; Fujiyoshi K; Sugiyama T; Ota S; Yoshimura O; Nishida T; Kamura T
    Gan To Kagaku Ryoho; 2001 May; 28(5):701-5. PubMed ID: 11383222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
    Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer.
    Raspagliesi F; Ditto A; Selvaggi L; Frigerio L; Melpignano M; Scambia G; Apolloni C; Scollo P; Pignata S; Panici PB
    Int J Gynecol Cancer; 2010 Dec; 20(9):1569-75. PubMed ID: 21119370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer.
    Park DC; Kim JH; Lew YO; Kim DH; Namkoong SE
    Gynecol Oncol; 2004 Jan; 92(1):59-63. PubMed ID: 14751139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
    Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
    Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
    J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix.
    Kokawa K; Nishimura R; Fujii T; Umesaki N
    Anticancer Res; 2007; 27(4C):2721-7. PubMed ID: 17695438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer.
    Chitapanarux I; Tonusin A; Sukthomya V; Charuchinda C; Pukanhapan N; Lorvidhaya V
    Gynecol Oncol; 2003 Jun; 89(3):402-7. PubMed ID: 12798702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effects of combination chemotherapy with irinotecan hydrochloride and cisplatin on cervical cancer: study of 46 patients].
    Wang CY; Ma D; Zhu T; Chen SY; Zhang QH; Song XJ; Chen TH; Gu MJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2104-8. PubMed ID: 16313818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer.
    Sugiyama T; Yakushiji M; Noda K; Ikeda M; Kudoh R; Yajima A; Tomoda Y; Terashima Y; Takeuchi S; Hiura M; Saji F; Takahashi T; Umesaki N; Sato S; Hatae M; Ohashi Y
    Oncology; 2000; 58(1):31-7. PubMed ID: 10644938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy.
    Matsumura M; Takeshima N; Ota T; Omatsu K; Sakamoto K; Kawamata Y; Umayahara K; Tanaka H; Akiyama F; Takizawa K
    Gynecol Oncol; 2010 Nov; 119(2):212-6. PubMed ID: 20709382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
    Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
    Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
    Shoji T; Takatori E; Furutake Y; Takada A; Nagasawa T; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Kumagai S; Yoshizaki A; Sato A; Sugiyama T
    Int J Clin Oncol; 2016 Dec; 21(6):1120-1127. PubMed ID: 27342833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.